Literature DB >> 25047668

Early onset and novel features in a spinal and bulbar muscular atrophy patient with a 68 CAG repeat.

Christopher Grunseich1, Ilona R Kats2, Laura C Bott3, Carlo Rinaldi2, Angela Kokkinis2, Derrick Fox2, Ke-Lian Chen2, Alice B Schindler2, Ami K Mankodi2, Joseph A Shrader4, Daniel P Schwartz5, Tanya J Lehky5, Chia-Ying Liu6, Kenneth H Fischbeck2.   

Abstract

Spinal and bulbar muscular atrophy (SBMA) is an X-linked neuromuscular disease caused by a trinucleotide (CAG) repeat expansion in the androgen receptor gene. Patients with SBMA have weakness, atrophy, and fasciculations in the bulbar and extremity muscles. Individuals with CAG repeat lengths greater than 62 have not previously been reported. We evaluated a 29year old SBMA patient with 68 CAGs who had unusually early onset and findings not seen in others with the disease. Analysis of the androgen receptor gene confirmed the repeat length of 68 CAGs in both peripheral blood and fibroblasts. Evaluation of muscle and sensory function showed deficits typical of SBMA, and in addition the patient had manifestations of autonomic dysfunction and abnormal sexual development. These findings extend the known phenotype associated with SBMA and shed new insight into the effects of the mutated androgen receptor. Published by Elsevier B.V.

Entities:  

Keywords:  Androgen receptor; Genetics; Kennedy’s disease; Motor neuron disease; Spinal bulbar muscular atrophy

Mesh:

Substances:

Year:  2014        PMID: 25047668      PMCID: PMC4252652          DOI: 10.1016/j.nmd.2014.06.441

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  21 in total

1.  Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy.

Authors:  Jessica L Walcott; Diane E Merry
Journal:  J Biol Chem       Date:  2002-10-17       Impact factor: 5.157

2.  Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor.

Authors:  Andrew P Lieberman; George Harmison; Andrew D Strand; James M Olson; Kenneth H Fischbeck
Journal:  Hum Mol Genet       Date:  2002-08-15       Impact factor: 6.150

3.  Epidermal nerve fiber density: normative reference range and diagnostic efficiency.

Authors:  J C McArthur; E A Stocks; P Hauer; D R Cornblath; J W Griffin
Journal:  Arch Neurol       Date:  1998-12

4.  Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait.

Authors:  W R Kennedy; M Alter; J H Sung
Journal:  Neurology       Date:  1968-07       Impact factor: 9.910

5.  CREB-binding protein sequestration by expanded polyglutamine.

Authors:  A McCampbell; J P Taylor; A A Taye; J Robitschek; M Li; J Walcott; D Merry; Y Chai; H Paulson; G Sobue; K H Fischbeck
Journal:  Hum Mol Genet       Date:  2000-09-01       Impact factor: 6.150

6.  Muscular weakness assessment: use of normal isometric strength data. The National Isometric Muscle Strength (NIMS) Database Consortium.

Authors: 
Journal:  Arch Phys Med Rehabil       Date:  1996-12       Impact factor: 3.966

7.  Variable expression of 5 alpha-reductase deficiency: presentation with male phenotype in a child of Greek origin.

Authors:  T O Carpenter; J Imperato-McGinley; S D Boulware; R M Weiss; C Shackleton; J E Griffin; J D Wilson
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

8.  Primary sensory neurons in X-linked recessive bulbospinal neuropathy: histopathology and androgen receptor gene expression.

Authors:  M Li; G Sobue; M Doyu; E Mukai; Y Hashizume; T Mitsuma
Journal:  Muscle Nerve       Date:  1995-03       Impact factor: 3.217

9.  Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy.

Authors:  M Li; S Miwa; Y Kobayashi; D E Merry; M Yamamoto; F Tanaka; M Doyu; Y Hashizume; K H Fischbeck; G Sobue
Journal:  Ann Neurol       Date:  1998-08       Impact factor: 10.422

10.  Small-fiber neuropathy with cardiac denervation in postural tachycardia syndrome.

Authors:  Carl-Albrecht Haensch; Marco Tosch; Istvan Katona; Joachim Weis; Stefan Isenmann
Journal:  Muscle Nerve       Date:  2014-08-29       Impact factor: 3.217

View more
  23 in total

1.  The clinical application of preimplantation genetic diagnosis for the patient affected by congenital contractural arachnodactyly and spinal and bulbar muscular atrophy.

Authors:  Linjun Chen; Zhenyu Diao; Zhipeng Xu; Jianjun Zhou; Wanjun Wang; Jie Li; Guijun Yan; Haixiang Sun
Journal:  J Assist Reprod Genet       Date:  2016-07-09       Impact factor: 3.412

Review 2.  Spinal and Bulbar Muscular Atrophy.

Authors:  Christopher Grunseich; Kenneth H Fischbeck
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

3.  The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy.

Authors:  Angela Rosenbohm; Susanne Hirsch; Alexander E Volk; Torsten Grehl; Julian Grosskreutz; Frank Hanisch; Andreas Herrmann; Katja Kollewe; Wolfram Kress; Thomas Meyer; Susanne Petri; Johannes Prudlo; Carsten Wessig; Hans-Peter Müller; Jens Dreyhaupt; Jochen Weishaupt; Christian Kubisch; Jan Kassubek; Patrick Weydt; Albert C Ludolph
Journal:  J Neurol       Date:  2018-02-20       Impact factor: 4.849

4.  Hypospadias as a novel feature in spinal bulbar muscle atrophy.

Authors:  Anna Skarin Nordenvall; Martin Paucar; Catarina Almqvist; Anna Nordenström; Louise Frisén; Agneta Nordenskjöld
Journal:  J Neurol       Date:  2016-02-12       Impact factor: 4.849

5.  A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy.

Authors:  Laura C Bott; Nisha M Badders; Ke-Lian Chen; George G Harmison; Elaine Bautista; Charles C-Y Shih; Masahisa Katsuno; Gen Sobue; J Paul Taylor; Nico P Dantuma; Kenneth H Fischbeck; Carlo Rinaldi
Journal:  Hum Mol Genet       Date:  2016-03-08       Impact factor: 6.150

Review 6.  In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.

Authors:  Maria Pennuto; Manuela Basso
Journal:  J Mol Neurosci       Date:  2015-11-27       Impact factor: 3.444

Review 7.  The Role of the Protein Quality Control System in SBMA.

Authors:  Paola Rusmini; Valeria Crippa; Riccardo Cristofani; Carlo Rinaldi; Maria Elena Cicardi; Mariarita Galbiati; Serena Carra; Bilal Malik; Linda Greensmith; Angelo Poletti
Journal:  J Mol Neurosci       Date:  2015-11-14       Impact factor: 3.444

Review 8.  Diagnostic Clinical, Electrodiagnostic and Muscle Pathology Features of Spinal and Bulbar Muscular Atrophy.

Authors:  Manu E Jokela; Bjarne Udd
Journal:  J Mol Neurosci       Date:  2015-11-16       Impact factor: 3.444

Review 9.  Kennedy's disease (spinal and bulbar muscular atrophy): a clinically oriented review of a rare disease.

Authors:  Marianthi Breza; Georgios Koutsis
Journal:  J Neurol       Date:  2018-07-13       Impact factor: 4.849

Review 10.  Spinal and Bulbar Muscular Atrophy Overview.

Authors:  Kenneth H Fischbeck
Journal:  J Mol Neurosci       Date:  2015-11-07       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.